Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation
Mitra Nair, Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Maninder Khosla(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jin Muk Kang(The University of Texas Health Science Center at Houston), Chelsea Bolyard(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Matthew Old, Balveen Kaur(Augusta University), Tae Jin Lee(Augusta University), Margaret Yeh, Yeshavanth Banasavadi‐Siddegowda(Neurological Surgery), Raphael E. Pollock(The Ohio State University), Flora Park(Rice University), Toshihiko Shimizu(The University of Texas Health Science Center), Gonzalo Lopez(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Yoshihiro Otani(Okayama University), Jun-Ge Yu(The Ohio State University Wexner Medical Center)
Cited by 18
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332
Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression
|Cancer Research|2017|199
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
|Annals of Surgery|2002|189